- Home
- ANIP vs FIGS Comparison
ANIP vs FIGS Comparison
Compare ANIP & FIGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- FIGS
- Stock Information
- Founded
- ANIP 2001
- FIGS 2013
- Country
- ANIP United States
- FIGS United States
- Employees
- ANIP N/A
- FIGS N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- FIGS Apparel
- Sector
- ANIP Health Care
- FIGS Consumer Discretionary
- Exchange
- ANIP Nasdaq
- FIGS Nasdaq
- Market Cap
- ANIP 2.0B
- FIGS 1.1B
- IPO Year
- ANIP N/A
- FIGS 2021
- Fundamental
- Price
- ANIP $96.09
- FIGS $7.32
- Analyst Decision
- ANIP Strong Buy
- FIGS Sell
- Analyst Count
- ANIP 9
- FIGS 4
- Target Price
- ANIP $86.00
- FIGS $5.38
- AVG Volume (30 Days)
- ANIP 439.9K
- FIGS 1.8M
- Earning Date
- ANIP 11-07-2025
- FIGS 11-06-2025
- Dividend Yield
- ANIP N/A
- FIGS N/A
- EPS Growth
- ANIP N/A
- FIGS N/A
- EPS
- ANIP N/A
- FIGS 0.04
- Revenue
- ANIP $747,399,000.00
- FIGS $569,581,000.00
- Revenue This Year
- ANIP $39.36
- FIGS $4.63
- Revenue Next Year
- ANIP $9.45
- FIGS $3.69
- P/E Ratio
- ANIP N/A
- FIGS $170.20
- Revenue Growth
- ANIP 38.68
- FIGS 3.41
- 52 Week Low
- ANIP $52.50
- FIGS $3.57
- 52 Week High
- ANIP $99.50
- FIGS $7.43
- Technical
- Relative Strength Index (RSI)
- ANIP 65.37
- FIGS 60.14
- Support Level
- ANIP $96.08
- FIGS $6.59
- Resistance Level
- ANIP $99.39
- FIGS $7.31
- Average True Range (ATR)
- ANIP 2.31
- FIGS 0.28
- MACD
- ANIP -0.70
- FIGS 0.02
- Stochastic Oscillator
- ANIP 62.77
- FIGS 77.99
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About FIGS FIGS Inc.
FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company generates maximum revenue from United States. Sales are generated through the Company's digital platforms.